Alzheimer Disease
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Published in Medical Imaging Law Weekly, June 5th, 2007
Avid Radiopharmaceuticals, Inc. (Avid), a product-focused molecular imaging company, announced the presentation of the first results from a clinical study of 18F-AV-1/ZK (AV-1), a novel radiopharmaceutical for positron emission tomography (PET) imaging of amyloid plaques in patients with Alzheimer's disease. Principal investigator Dr. Christopher Rowe from Austin Hospital of Melbourne, a leading investigator in the field of molecular imaging of Alzheimer's disease, presented the results at the 8th International Conference on AD/PD in Salzburg, Austria.
The goal of this first clinical study was to examine whether PET imaging with AV-1 could be used to distinguish...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly
More Articles from Medical Imaging Law Weekly
- Adenoma
Studies from Kyoto University yield new data on adenoma - Adrenoleukodystrophy
Data on adrenoleukodystrophy reported by researchers at Harvard University, Martinos Center for Biomedical Imaging - Alliance Imaging, Inc.
Alliance Imaging Announces the Purchase of a Significant Interest in Alliance by Oaktree Capital Management, LLC and MTS Health Investors, LLC - Alzheimer Disease
Research from University of Texas, Department of Physiology in the area of Alzheimer disease described - Amyotrophic Lateral Sclerosis
Researchers from Emory University, Department of Neurology publish new studies and findings in the area of amyotrophic lateral sclerosis - Analytical Chemistry
Imperial College London describes research in analytical chemistry - More from this issue of Medical Imaging Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
